期刊文献+

进行性核上性麻痹4例临床分析 被引量:2

CLINICAL ANALYSIS OF FOUR PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY
在线阅读 下载PDF
导出
摘要 [目的]探讨进行性核上性麻痹的发病机制、病理特点、诊断及治疗。[方法]分析4例进行性核上性麻痹患者的临床资料,并复习相关文献。[结果]4例患者均于55岁后缓慢起病,临床表现为姿势不稳、帕金森综合征、垂直性核上性眼肌麻痹、假性球麻痹和痴呆等症状。进行性核上性麻痹的发病机制尚不明确。氧化应激和线粒体功能失调等可能导致了tau蛋白的沉积。病理表现为皮层及皮层下结构神经细胞丢失,神经纤维缠结和胶质增生。其诊断和神经影像学已经得到发展,但尚无有效治疗措施。[结论]进行性核上性麻痹是一种误诊率很高的疾病,临床医生应予重视。 [Objective] To investigate the pathogenesis, pathology, diagnosis and treatment of progressive supranuclear palsy. [ Methods] The clinical data of four patients with progressive supranuclear palsy were analyzed, and the related literatures of this disease were reviewed. [Results] The onset of the four cases was slowly progressive after 55-year old, characterized by postural instability, Parkinsonism, vertical supranuclear gaze palsy, pseudobulbar palsy and dementia. The pathogenesis of progressive supranuclear palsy was still uncertain. Oxidative damage and mitochondrial dysfunction might contribute to tau deposition. The pathological changes involved with both cortical and subcortical structures of the cerebrum, and manifestated by neuronal loss, spherical neurofibrillary tangles and gliosis. The diagnosis and neuroimage was improved, but there was no effective pharmaceutical intervention. [Conclusion] The disease of progressive supranuclear palsy is commonly misdiagnosed. Clinicians should pay more attention to it.
出处 《现代预防医学》 CAS 北大核心 2007年第5期964-965,968,共3页 Modern Preventive Medicine
关键词 进行性核上性麻痹 神经病理 诊断 Progressive supranuclear palsy Neuropathology Diagnosis
  • 相关文献

参考文献15

  • 1Avila J.Tau aggregation into fibrillar polymers:taupathies[J].FEBS Letters,2000,476 (1-2):89-92.
  • 2Tetrud JW,Golbe LI,Forno LS,et al.Autopsyproven progressive supranuclear palsy in two siblings[J].Neurology,1996,46:931-934.
  • 3Conrad C,Andreadis A,Trojanowski JQ,et al.Genetic evidence for the involvement of tau in progressive supranuclear palsy[J].Ann Neurol,1997,41:277-281.
  • 4Albers DS,Augood SJ,Park LC,et al.Frontal lobe dysfunction in progressive supranuclear palsy:evidence for oxidative stress and mitochondrial impairment[J].Neurochem,2000,74:878-881.
  • 5Cantuti-Castelvetri I,Keller-McGandy C.E.,Albers D S,et al.Expression and activity of antioxidants in the brain in progressive supranuclear palsy[J].Brain Res,2002,930:170-181.
  • 6Chirichigno JW,Manfredi G,Beal MF,et al.Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids[J].Brain Research,2002,951 (1):31-5.
  • 7Rajput,A.,Rajput,A.H.Progressive supranuclear palsy:clinical features,pathophysiology and management[J].Drugs Aging,2001,18:913-925.
  • 8Gearing M,Olson DA,Watts RL,et al.Progressive supranuclear palsy:Neuropathologic and clinical heterogeneity[J].Neurology,1994,44:1015-24.
  • 9Koichi W,Hitoshi T.Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration[J].Neuropathology,2004,24:79-86.
  • 10Uchikado H,DelleDonne A,Ahmed Z,et al.Lewy bodies in progressive supranuclear palsy represent an independent disease process[J].Journal of Neuropathology & Experimental Neurology,2006,65 (4):387-95.

同被引文献44

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部